BritDB

FTS UK public procurement

NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025

NHS England

CompleteOCDS ID ocds-h6vhtk-055064
Tender value£1,520,432,2953 awards · 2 contracts

01 Procurement

Tender overview

Updated 6 October 2025
Buyer
NHS England
Status
Complete
Procurement method
Open procedure
Category
goods
CPV classification
Not supplied
Tender period
Not supplied — 14 July 2025

Description

NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 Offer reference number: CM/PHS/25/5728 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/PHS/25/5728/01 - National Framework for Medical Retinal Vascular Treatments: 7NAT (National) 01/12/2025 to 31/05/2027 (18 months) CM/PHS/25/5728/02 - Regional Framework for Medical Retinal Vascular Treatments aflibercept 2mg: NOFE: (North of England) 01/12/2025 to 31/05/2027 (18 months) SOFE: (South of England) 01/12/2025 to 31/05/2027 (18 months) MAE: (Midlands and East) 01/12/2025 to 31/05/2027 (18 months) LNW: (London) 01/12/2025 to 31/05/2027 (18 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Provision of Licensed Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; • neovascular (wet) age-related macular degeneration (AMD) • visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) • proliferative diabetic retinopathy (PDR) • visual impairment due to diabetic macular oedema (DME) • visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy • vision impairment associated with chronic diabetic macular oedema, (DME) • visual impairment due to myopic choroidal neovascularisation (myopic CNV) • retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease • inflammation of the posterior segment of the eye presenting as non-infectious uveitis • prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye

i

This page represents one OCDS contracting process. Notices can be revised over time. Values may be estimates, award values or contract values and should be read with their displayed stage and date.

02 Awards and contracts

Published award records

3 shown
Pending

Lot 1 - CM/PHS/25/5728/01

Awarded
30 July 2025
Award value
£688,834,174
Suppliers
10
Signed contract
Not supplied
Active

Lot 2 - CM/PHS/25/5728/02

Awarded
30 July 2025
Award value
£782,917,972
Suppliers
14
Signed contract
21 September 2025
Active

NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025

Awarded
Not supplied
Award value
Not supplied
Suppliers
5
Signed contract
21 September 2025

03 Organisations

Buyers, suppliers and other parties

32 parties
Buyer

NHS ENGLAND

NHS England, 7&8 Wellington Place, Leeds, UKE42, LS1 4AP, United Kingdom

GB-NHS X24
Buyer

NHS England

Wellington House, 133-135 Waterloo Rd, London, UKI45, SE1 8UG, United Kingdom

GB-PPON PDPT-3135-BWWY
Supplier

Abbvie Ltd

Abbvie House Vanwall Business Park, Maidenhead, UKJ11, SL6 4UB, United Kingdom

GB-PPON PHRQ-1133-WGCH
Supplier

Alimera Sciences

Form 1 Bartley Wood Business Park, Hook, UKJ37, RG27 9XA, United Kingdom

GB-PPON PYCZ-7339-TCCT
Supplier, Tenderer

ALIMERA SCIENCES LIMITED

Form 1 Bartley Wood Business Park, Hook, UKJ37, RG27 9XA, United Kingdom

Companies House 08018355 →
Supplier

Bayer Plc

400 South Oak Way, Reading, UKJ11, RG2 6AD, United Kingdom

GB-PPON PWRY-2527-LDRY
Supplier

Biogen

Building 5 Foundation Park, Maidenhead, UKJ11, SL63UD, United Kingdom

GB-PPON PTGT-3385-PBMQ
Supplier

BIOSIMILAR COLLABORATIONS IRELAND LIMITED

Biocon Biologics 16 Great Queen Street, London, UKI31, WC2B 5AH, United Kingdom

GB-PPON PQQC-5869-LMVX
Supplier, Tenderer

CELLTRION HEALTHCARE UNITED KINGDOM LIMITED

The Charter Building, Uxbridge, UKI74, UB8 1JG, United Kingdom

Companies House 11685363 →
Supplier

Celltrion Healthcare United Kingdom Limited

Celltrion Healthcare UK Limited, The Charter Building, Charter Place, Uxbridge, UKI74, UB8 1JG, United Kingdom

GB-PPON PYQL-4248-PXXY
Supplier

MDBIOLOGICS LTD

71-75 Shelton Street, London, UKI31, WC2H 9JQ, United Kingdom

GB-PPON PMHC-1596-RTNX
Supplier, Tenderer

NOVARTIS PHARMACEUTICALS UK LIMITED

2nd Floor, The Westworks Building White City Place, London, UKI33, W12 7FQ, United Kingdom

Companies House 00119006 →
Supplier

Novartis Pharmaceuticals UK Ltd

2nd Floor, The Westworks Building White City Place, London, UKI33, W12 7FQ, United Kingdom

GB-PPON PJTX-5182-QVLR
Supplier

Orion Pharma (UK) Ltd

The Scalpel, 18th Floor, London, UKI31, EC3M 7AF, United Kingdom

GB-PPON PJZQ-1429-ZBVY
Supplier

Outlook Therapeutics, Inc.

3rd Floor One London Square, Cross Lanes, Guildford,, Surrey, UKJ25, GU1 1UN, United Kingdom

GB-PPON PGZH-1763-NPGX
Supplier

Roche Products Ltd

6 Falcon Way, Welwyn Garden City, UKH23, AL7 1TW, United Kingdom

GB-PPON PXCG-4172-CHYM
Supplier

SANDOZ LIMITED

Maxis 1, Western Road, Bracknell, UKJ11, RG12 1RF, United Kingdom

GB-PPON PNQL-1548-CYBZ
Supplier

Teva UK Limited

Ridings Point, Castleford, UKE45, WF10 5HX, United Kingdom

GB-PPON PWDD-6894-DXRM
Supplier, Tenderer

THORNTON & ROSS LIMITED

Linthwaite Labs Manchester Road, Huddersfield, UKE44, HD7 5QH, United Kingdom

Companies House 00185947 →
Supplier

Thornton and Ross Ltd

Linthwaite Labs Manchester Road, Huddersfield, UKE44, HD7 5QH, United Kingdom

GB-PPON PWYH-6892-QYNN

Companies House links appear only for explicit GB-COH identifiers. BritDB does not create company links from a similar name or address.

04 Provenance

Source for this process

FTS
Find a Tender OCDS data

Official UK procurement releases compiled into one process record.

Snapshot 22 August 2026→

Contains public sector information licensed under the Open Government Licence v3.0. Official external links are available only on the source transition page.